Patents by Inventor Peter Jones

Peter Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160334348
    Abstract: This disclosure relates to medical fluid sensors and related systems and methods. In some aspects, a medical fluid cartridge includes a body including a first portion defining a first fluid passageway and a second portion defining a second fluid passageway in fluid communication with the first fluid passageway. The body defines a gap between the first portion of the body and the second portion of the body such that the first portion of the body can be disposed in a radio frequency device while the second portion of the body remains outside the radio frequency device.
    Type: Application
    Filed: July 29, 2016
    Publication date: November 17, 2016
    Inventor: Ross Peter Jones
  • Patent number: 9470789
    Abstract: A movable platform has a front end, a back end, a longitudinal axis, and at least one axle oriented generally transverse to the longitudinal axis and located between the front and back ends for supporting wheels of the platform. A position sensor is affixed on the platform at a location other than at a location defined by a plane passing through the axle and normal to the longitudinal axis. The position sensor provides position data as the platform traverses a path. A sensor arrangement is supported by the platform and configured to provide subsurface sensor data as the platform traverses the path. A processor is configured to associate the position data with the sensor data relative to a reference frame and in a manner that accounts for dynamic motion of the platform.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: October 18, 2016
    Assignee: UNDERGROUND IMAGING TECHNOLOGIES, INC.
    Inventors: Ross Peter Jones, Peter John Kelly
  • Patent number: 9433718
    Abstract: This disclosure relates to medical fluid sensors and related systems and methods. In some aspects, a medical fluid cartridge includes a body including a first portion defining a first fluid passageway and a second portion defining a second fluid passageway in fluid communication with the first fluid passageway. The body defines a gap between the first portion of the body and the second portion of the body such that the first portion of the body can be disposed in a radio frequency device while the second portion of the body remains outside the radio frequency device.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 6, 2016
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventor: Ross Peter Jones
  • Patent number: 9399146
    Abstract: A photodynamic therapy lamp includes two lamp modules comprising an array of LEDs. Each of the lamp modules is movable between a first position in which an angle between the lamp modules is from 157 degrees to 180 degrees, and a second position in which the angle between the lamp modules is from 50 degrees to 70 degrees.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: July 26, 2016
    Assignee: Photocure ASA
    Inventors: Ross Peter Jones, Michael John Cox, Euan Morrison
  • Publication number: 20160197736
    Abstract: A connectivity device, such as a switch may consume lesser power by transitioning into stand-by mode in response to a command from an upstream connectivity device, such as another switch. In the stand-by mode the switch may power down circuitry of the switch that handles incoming messages. The switch may be powered up from the stand-by mode by using a PHY or Layer-1 components of the switch.
    Type: Application
    Filed: January 2, 2015
    Publication date: July 7, 2016
    Inventors: Leonid Shvarzberg, Peter Jones, Chris Desiniotis, Krishna Kumar Vavilala
  • Publication number: 20160177398
    Abstract: A method for the prediction, prognosis and/or diagnosis of bladder cancer or bladder cancer recurrence in a subject, the method includes: providing a test sample from the subject; measuring DNA methylation levels of at least a portion of two or more polynucleotides selected from the group consisting of HOXA9, SOXI, NPY, IRAK3, L1-MET, and Z02 in the test sample; calculating a risk score based on the measured DNA methylation levels, comparing the calculated risk score to a cut-off value derived from a reference DNA methylation profile based on DNA methylation levels of the one or more biomarkers derived from a control group, members of which had bladder cancer; and based on the comparison calculated risk score to the cut-off value, determining at least one of: (1) whether bladder cancer has recurred; (2) whether there is likelihood that the bladder cancer will recur; and (3) whether the patient has bladder cancer.
    Type: Application
    Filed: May 9, 2014
    Publication date: June 23, 2016
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Sheng-Fang SU, Gangning Liang, Peter JONES, Kimberly SIEGMUND
  • Publication number: 20160132322
    Abstract: An example method of updating firmware includes receiving a memory map of a memory. The method also includes determining, based on the memory map, a set of memory regions storing a bundle of drivers in the memory, the bundle of drivers residing in firmware and being in an executable format. The method further includes for one or more drivers in the bundle of drivers (i) building, based on the memory map, a header that describes the respective driver, and (ii) creating an object file including the header and the respective driver, where the object file is in the executable format. The method also includes storing one or more of the object files in non-volatile memory.
    Type: Application
    Filed: November 11, 2014
    Publication date: May 12, 2016
    Inventors: Peter Jones, Adam Jackson
  • Patent number: 9325506
    Abstract: A system and method are disclosed for enforcing site or organization localized provisioning policy using cryptography. In an exemplary method, a signing key is used to generate a signature for an application. The signature of the application is verified using a verifying key in order to determine whether the application adheres to the site or organization localized provisioning policy. The verifying may be performed during initialization of a computing device or during runtime of an operating system at the computing device.
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: April 26, 2016
    Assignee: Red Hat, Inc.
    Inventors: Peter Jones, David Cantrell
  • Publication number: 20160090381
    Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 24, 2015
    Publication date: March 31, 2016
    Inventors: MARK EDWARD SCHNUTE, ANDREW CHRISTOPHER FLICK, PETER JONES, NEELU KAILA, SCOT RICHARD MENTE, JOHN DAVID TRZUPEK, MICHAEL L. VAZQUEZ, GÖRAN MATTIAS WENNERSTÅL, LI XING, EDOUARD ZAMARATSKI, LIYING ZHANG
  • Publication number: 20160087801
    Abstract: A system and method are disclosed for enforcing site or organization localized provisioning policy using cryptography. In an exemplary method, a signing key is used to generate a signature for an application. The signature of the application is verified using a verifying key in order to determine whether the application adheres to the site or organization localized provisioning policy. The verifying may be performed during initialization of a computing device or during runtime of an operating system at the computing device.
    Type: Application
    Filed: September 23, 2014
    Publication date: March 24, 2016
    Inventors: Peter Jones, David Cantrell
  • Publication number: 20160046597
    Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 18, 2016
    Inventors: Mark Edward Schnute, Göran Mattias Wennerstål, James Robert Blinn, Neelu Kaila, James Richard Kiefer, JR., Scot Richard Mente, Ravi G. Kurumbail, Marvin Jay Meyers, Atli Thorarensen, Li Xing, Christoph Wolfgang Zapf, Edouard Zamaratski, Andrew Christopher Flick, Peter Jones
  • Publication number: 20160008623
    Abstract: A photodynamic therapy lamp includes two lamp modules comprising an array of LEDs. Each of the lamp modules is movable between a first position in which an angle between the lamp modules is from 157 degrees to 180 degrees, and a second position in which the angle between the lamp modules is from 50 degrees to 70 degrees.
    Type: Application
    Filed: September 24, 2015
    Publication date: January 14, 2016
    Applicant: PHOTOCURE ASA
    Inventors: Ross Peter JONES, Michael John COX, Euan MORRISON
  • Publication number: 20150377081
    Abstract: A cam rocker lever comprises an annular piece with an inner diameter, a cam lobe, a first linear portion, and a second linear portion. The cam lobe is disposed within the inner diameter of the annular piece. The first linear portion extends from a first side of the annular piece, and a second linear portion extends from a second side of the annular piece opposite the first side. The first linear portion is configured to connect to a stem of a valve such that the valve is displaced when the first linear portion is displaced.
    Type: Application
    Filed: June 29, 2015
    Publication date: December 31, 2015
    Applicant: Cummins Inc.
    Inventor: John Peter Jones
  • Publication number: 20150329542
    Abstract: A compound having the structure: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein A and A? are independently C or N, where C may be unsubstituted or substituted by halo or C1-C6 alkyl; R and R0 are independently selected from the group consisting of H, C1-C6 alkyl, hydroxy(C1-C6 alkyl), phenyl(C1-C6 alkyl), and —(CH2)n—W, where W is C3-C8 cycloalkyl, phenyl, naphthyl, 5- or 6-membered heteroaryl or heterocyclic containing 1-3 N, S and/or O atoms, —SO2—R?, —NHSO2—R?, —NR?SO2—R? and SR?, where R? and R? are independently C1-C6 alkyl or C3-C8 cycloalkyl, etc.; wherein each of said alkyl, cycloalkyl, heterocyclic, phenyl, naphthyl or heteroaryl may be unsubstituted or substituted by phenyl, heteroaryl, etc.
    Type: Application
    Filed: May 13, 2015
    Publication date: November 19, 2015
    Inventors: Jotham Wadsworth Coe, Christoph Martin Dehnhardt, Peter Jones, Yogesh Anil Sabnis, Joseph Walter Strohbach, Florian Michel Wakenhut, Gavin Alistair Whitlock
  • Patent number: 9138748
    Abstract: A reaction vessel for conducting a chemical or biochemical reaction, such as a polymerase chain reaction wherein at least one wall of said vessel comprises a metallic layer and an inner non-metallic layer. Reaction systems comprising combinations of vessels of the invention and apparatus for heating them, as well as particular reactions vessels are also described and claimed.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: September 22, 2015
    Assignee: ENIGMA DIAGNOSTICS LIMITED
    Inventors: Martin Alan Lee, David James Squirrell, Ross Peter Jones, Roger James Williamson, George Richard Gregory, Graham Gutsell
  • Publication number: 20150215237
    Abstract: A method for allocating port assignments for transmitting a reserved network stream across a network node comprises determining a cycle time associated with a network node. The method also comprises establishing, for at least one port of the network node, a plurality of virtual layers associated with the cycle time, wherein each of the plurality of virtual layers is divided into 2n equally-spaced slots per cycle (where n>0). The method further comprises receiving a reserved stream request associated with transmission of a reserved stream across the node, and determining a number of slots required to transmit the reserved stream. The method also comprises assigning one or more slots associated with a port of the network node to the transmission of packets associated with the reserved stream based on the determined number of slots. The method further comprises transmitting the stream according to the slot assignment associated with the port of the network node.
    Type: Application
    Filed: January 25, 2014
    Publication date: July 30, 2015
    Inventors: Norman Finn, Rong Pan, Hiroshi Suzuki, Linda Cheng, Peter Jones, Hari Ginjpalli, Rudy Klecka
  • Publication number: 20150210655
    Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 30, 2015
    Applicant: ASTRAZENECA AB
    Inventors: Hans Roland LONN, Stephen CONNOLLY, Steven SWALLOW, Staffan PO KARLSSON, Carl-Johan AURELL, John Fritiof PONTÉN, Kevin James DOYLE, Amanda Jane VAN DE POËL, Graham Peter JONES, David Wyn WATSON, Jaqueline Anne MACRITCHIE, Nicholas John PALMER
  • Publication number: 20150204299
    Abstract: Exemplary embodiments of the invention provide an apparatus and method for generating power from a renewable source of environmental water. The apparatus includes an upstanding structure adapted for support on ground adjacent to the renewable source of water having an elevated region relative to the ground. A conduit for water extends between the elevated region of the water supply and a water inlet. A gravity-operated energy converter supported by the structure is provided that causes water to descend vertically between the inlet and an outlet adjacent the ground while utilizing the weight of the water thus descending to drive at least one movable element and thereby produce power. Additional energy may be provided from buoyancy by causing empty and inverted water containers to ascend through a column of water fed by the renewable source of water.
    Type: Application
    Filed: February 15, 2013
    Publication date: July 23, 2015
    Inventor: Peter A. Jones
  • Patent number: 8995833
    Abstract: In an automatically switched optical network operating according to a wavelength plan, the wavelengths are assigned to an optical path based on availability, performance and SRS wavelength coupling reduction. First, the wavelengths are grouped in static bins based on their reach versus cost performance, and each bin assumes a ?Q of a middle wavelength. Then, the bins are moved into subsets of dynamic bins, constructed using bin constraints that account for the particulars of the respective optical path. The path is characterized taking into account the wavelength currently accessing at the end nodes, and the wavelength tandeming through the end nodes. Wavelength selection starts with the bins that satisfy the maximum number of constraints, and the wavelengths are checked sequentially against wavelength constraints; relaxed constraints are also applied when it is not possible to exactly satisfy one or more constraints.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: March 31, 2015
    Assignee: Alcatel Lucent
    Inventors: John Peter Guy, Peter David Roorda, Alan Glen Solheim, Kevan Peter Jones, Greg Peter Friesen
  • Publication number: 20150055953
    Abstract: In an automatically switched optical network operating according to a wavelength plan, the wavelengths are assigned to an optical path based on availability, performance and SRS wavelength coupling reduction. First, the wavelengths are grouped in static bins based on their reach versus cost performance, and each bin assumes a ?Q of a middle wavelength. Then, the bins are moved into subsets of dynamic bins, constructed using bin constraints that account for the particulars of the respective optical path. The path is characterized taking into account the wavelength currently accessing at the end nodes, and the wavelength tandeming through the end nodes. Wavelength selection starts with the bins that satisfy the maximum number of constraints, and the wavelengths are checked sequentially against wavelength constraints; relaxed constraints are also applied when it is not possible to exactly satisfy one or more constraints.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 26, 2015
    Applicant: Alcatel-Lucent USA Inc.
    Inventors: John Peter Guy, Peter David Roorda, Alan Glen Solheim, Kevan Peter Jones, Greg Peter Friesen